drugset / Trial / NCT00208923
Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Patients who have cancer of the bone marrow (leukemia) or lymph gland (lymphomas) are being asked to take part in this study. This study uses a new chemotherapy regimen and matched volunteer stem cell transplant to treat patients with cancers of this kind.
Timeline
- Start
- 1998-07
- Primary completion
- 2007-10
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Busulfan | Small molecule | 0.8 mg/kg | Oral |
| Comparator | Busulfan | Small molecule | 1 mg/kg | Oral |
| Comparator | Cyclophosphamide | Other / unclassified | 60 mg/kg | Intravenous |
| Comparator | Fludarabine | Small molecule | 40 mg/m2 | Intravenous |